Benzylone (also known as 3,4-Methylenedioxy-N-benzylcathinone or BMDP), is a recreational designer drug from the substituted cathinone family, with stimulant effects. It has been commonly encountered in seizures of street drug samples but appears to have relatively low potency on its own, being mainly found as a component of mixtures with other related drugs.[1][2][3]

Benzylone
Identifiers
  • 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H17NO3
Molar mass283.327 g·mol−1
3D model (JSmol)
  • CC(C(=O)C1=CC2=C(C=C1)OCO2)NCC3=CC=CC=C3
  • InChI=1S/C17H17NO3/c1-12(18-10-13-5-3-2-4-6-13)17(19)14-7-8-15-16(9-14)21-11-20-15/h2-9,12,18H,10-11H2,1H3
  • Key:KRNIYOJEASBDDP-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ Mueller DM, Rentsch KM (February 2012). "Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones" (PDF). Analytical and Bioanalytical Chemistry. 402 (6): 2141–2151. doi:10.1007/s00216-011-5678-8. PMID 22231510. S2CID 27846319.
  2. ^ Fornal E, Stachniuk A, Wojtyla A (January 2013). "LC-Q/TOF mass spectrometry data driven identification and spectroscopic characterisation of a new 3,4-methylenedioxy-N-benzyl cathinone (BMDP)". Journal of Pharmaceutical and Biomedical Analysis. 72: 139–144. doi:10.1016/j.jpba.2012.09.019. PMID 23146238.
  3. ^ Critical Review Report: 3,4-Methylenedioxy-N-benzylcathinone (Benzylone, BMDP). World Health Organization. Expert Committee on Drug Dependence Forty-fourth Meeting, Geneva, 11-15 October 2021